CG Oncology, Inc. chief commercial officer Isabel Kalofonos buys $299,161 of stock, first buy in 12 months
3,751 shares at about $79.76 each, bought on the open market on Nov 18.
Isabel Kalofonos purchased about $300,000 of CG Oncology, Inc. (CGON) stock on Nov 18, according to an SEC filing. The chief commercial officer paid an average of $79.76 for 3,751 shares.
It is an open-market purchase (transaction code P) of common stock, the kind of trade insiders make with their own money. The trade was reported within two business days, as Section 16 requires.
No other open-market purchase at CG Oncology, Inc. was reported in the previous 90 days. It is the insider's first open-market purchase of CGON in at least 12 months.
Details from the SEC filing:
| Company | CG Oncology, Inc. (CGON) |
|---|---|
| Insider | Isabel Kalofonos |
| Role | Chief Commercial Officer |
| Transaction | Open-market purchase (code P) |
| Shares | 3,751 |
| Average price | $79.76 |
| Value | $299,161 |
| Trade date | Nov 18, 2026 |
| Filed with the SEC | Nov 18, 2026, 4:30 PM ET |
| Shares held after | 3,751 |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
See the full details of this insider trade
Read more CGON insider trading news · See where several insiders traded together
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.